Skip to content
Peptide research

Endoluten

Also known as Pineal Bioregulator
Category
Bioregulators
Administration routes
Oral
Regulatory status
Not FDA-approved

What it is

A bovine pineal-derived bioregulator peptide marketed to restore declining pineal function, melatonin output, and circadian rhythm. Human evidence is thin: melatonin normalization is extrapolated from Epithalamin studies, but neuroendocrine, cardiovascular, and anti-aging claims rest on weak or speculative data. Human safety data is minimal, with a low risk of allergic reaction. Not FDA-approved; most supply consists of unregulated products sold online.

Read Full record

Studied uses & evidence

Studied uses(5)

  • Melatonin secretion normalization during aging

    Speculative

    Nighttime melatonin restoration is shown for injectable Epithalamin, not directly tested for oral Endoluten.

  • Neuroendocrine system regulation

    Low

    Mostly animal and cell data; human evidence limited to open-label studies with soft endpoints.

  • Circadian rhythm support

    Low

    Inferred from melatonin and blood pressure rhythm data, not measured with sleep studies.

Evidence limits

Evidence Level
Limited Evidence (with stronger data for related injectable form)

Direct clinical evidence for oral Endoluten capsules is limited to Russian clinical reports. However, the related injectable form Epithalamin and synthetic peptide Epitalon have more extensive published research, including long-term human follow-up studies showing mortality reduction (Kiev study, 6-12 year follow-up), telomerase activation studies, and melatonin normalization data. The oral capsule form is extrapolated from these findings but has not been independently validated.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(3)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Allergic reaction to bovine pineal-derived peptides

    Low
  • Interaction with melatonin supplements

    Low
  • Hormonal effects in hormone-sensitive conditions

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.